Sclerostin small molecule inhibitors promote osteogenesis by activating canonical Wnt and BMP pathways.
Sreedhara SangadalaChi Heon KimLorenzo M FernandesPooja MakkaraGeorge R BeckScott D BodenHicham DrissiSteven M PresciuttiPublished in: eLife (2023)
Funding: This work was supported by a Veteran Affairs Career Development Award (IK2-BX003845).